Peters Harold O, Mendoza Mark G, Capina Rupert E, Luo Ma, Mao Xiaojuan, Gubbins Michael, Nagelkerke Nico J D, Macarthur Ian, Sheardown Brent B, Kimani Joshua, Wachihi Charles, Thavaneswaran Subo, Plummer Francis A
National Microbiology Laboratory, 1015 Arlington St., Winnipeg, Manitoba R3E 3R2, Canada.
J Virol. 2008 Feb;82(4):1980-92. doi: 10.1128/JVI.02742-06. Epub 2007 Dec 5.
Human immunodeficiency virus type 1 (HIV-1) is able to evade the host cytotoxic T-lymphocyte (CTL) response through a variety of escape avenues. Epitopes that are presented to CTLs are first processed in the presenting cell in several steps, including proteasomal cleavage, transport to the endoplasmic reticulum, binding by the HLA molecule, and finally presentation to the T-cell receptor. An understanding of the potential of the virus to escape CTL responses can aid in designing an effective vaccine. To investigate such a potential, we analyzed HIV-1 gag from 468 HIV-1-positive Kenyan women by using several bioinformatic approaches that allowed the identification of positively selected amino acids in the HIV-1 gag region and study of the effects that these mutations could have on the various stages of antigen processing. Correlations between positively selected residues and mean CD4 counts also allowed study of the effect of mutation on HIV disease progression. A number of mutations that could create or destroy proteasomal cleavage sites or reduce binding affinity of the transport antigen processing protein, effectively hindering epitope presentation, were identified. Many mutations correlated with the presence of specific HLA alleles and with lower or higher CD4 counts. For instance, the mutation V190I in subtype A1-infected individuals is associated with HLA-B*5802 (P = 4.73 x 10(-4)), a rapid-progression allele according to other studies, and also to a decreased mean CD4 count (P = 0.019). Thus, V190I is a possible HLA escape mutant. This method classifies many positively selected mutations across the entire gag region according to their potential for immune escape and their effect on disease progression.
1型人类免疫缺陷病毒(HIV-1)能够通过多种逃逸途径逃避宿主细胞毒性T淋巴细胞(CTL)反应。呈递给CTL的表位首先在呈递细胞中经过几个步骤进行处理,包括蛋白酶体切割、转运至内质网、与HLA分子结合,最后呈递给T细胞受体。了解病毒逃避CTL反应的潜力有助于设计有效的疫苗。为了研究这种潜力,我们通过几种生物信息学方法分析了468名HIV-1阳性肯尼亚女性的HIV-1 gag基因,这些方法能够识别HIV-1 gag区域中正向选择的氨基酸,并研究这些突变可能对抗原加工各个阶段产生的影响。正向选择的残基与平均CD4细胞计数之间的相关性还使得我们能够研究突变对HIV疾病进展的影响。我们鉴定出了一些能够产生或破坏蛋白酶体切割位点或降低转运抗原加工蛋白结合亲和力的突变,这些突变有效地阻碍了表位呈递。许多突变与特定HLA等位基因的存在以及较低或较高的CD4细胞计数相关。例如,A1亚型感染个体中的V190I突变与HLA-B*5802相关(P = 4.73×10⁻⁴),根据其他研究,这是一个与疾病快速进展相关的等位基因,并且还与平均CD4细胞计数降低相关(P = 0.019)。因此,V190I可能是一个HLA逃逸突变体。该方法根据其免疫逃逸潜力及其对疾病进展的影响,对整个gag区域的许多正向选择突变进行了分类。